Concepedia

Jill Walker

JW

Statistics

Publications

8

Citations

209

H-Index

8

Active since

2013

Affiliations

GlaxoSmithKline (United States)(Current)

Research Triangle Park Foundation

GlaxoSmithKline (United Kingdom)

Jill Walker is an author at GlaxoSmithKline (United States) specializing in antiviral pharmacology, antiviral therapy, and viral hepatitis.

Publications per year

2013–2019

8

Publications

8

Discovery of a Potent Boronic Acid Derived Inhibitor of the HCV RNA-Dependent RNA Polymerase

Andrew Maynard, Renae M. Crosby, Byron Ellis et al. · Journal of Medicinal Chemistry · 2013 · 56 citations · Full text

, , +17

Novel Spiroketal Pyrrolidine GSK2336805 Potently Inhibits Key Hepatitis C Virus Genotype 1b Mutants: From Lead to Clinical Compound

Wieslaw M. Kazmierski, Andrew Maynard, Maosheng Duan et al. · Journal of Medicinal Chemistry · 2014 · 43 citations · Full text

, , +17

Preclinical Characterization of GSK2336805, a Novel Inhibitor of Hepatitis C Virus Replication That Selects for Resistance in NS5A

Jill Walker, Renae M. Crosby, Amy Wang et al. · Antimicrobial Agents and Chemotherapy · 2013 · 23 citations · Full text

, , +17

Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of GSK2336805, an Inhibitor of Hepatitis C Virus (HCV) NS5A, in Healthy Subjects and Subjects Chronically Infected with HCV Genotype 1

David Wilfret, Jill Walker, Kimberly K. Adkison et al. · Antimicrobial Agents and Chemotherapy · 2013 · 22 citations · Full text

, , +17

<i>In Vitro</i> Characterization of GSK2485852, a Novel Hepatitis C Virus Polymerase Inhibitor

Christian Voitenleitner, Renae M. Crosby, Jill Walker et al. · Antimicrobial Agents and Chemotherapy · 2013 · 19 citations · Full text

, , +17

1–5 of 8